Results 151 to 160 of about 27,357 (215)

Posaconazole-induced primary adrenal insufficiency concomitant with pseudoaldosteronism under normal blood pressure. [PDF]

Endocrinol Diabetes Metab Case Rep
Katsumata M, Miura M, Masuzawa M.
europepmc   +1 more source

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

New England Journal of Medicine, 2007
A. Ullmann, J. Lipton, D. Vesole, P. Chandrasekar, A. Langston, S. Tarantolo, H. Greinix, Wellington Morais de Azevedo, V. Reddy, N. Boparai, L. Pedicone, H. Patiño, S. Durrant   +12 more
semanticscholar   +1 more source

Induced pluripotent stem cell-derived human macrophages as an infection model for Trypanosoma cruzi. [PDF]

PLoS Negl Trop Dis
Baert L, Cal M, Doll T, Müller M, Mäser P, Kaiser M.   +5 more
europepmc   +1 more source

Establishment and Validation of a UPLC-MS/MS Method for Quantitative Determination of Zanubrutinib and Posaconazole in Rat Plasma: Application in Drug-Drug Interaction Studies. [PDF]

Drug Des Devel Ther
Xia H, Shen Y, Xu X, Wu J, Lin G, Du X.
europepmc   +1 more source

Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review. [PDF]

Mycoses
Song Y, Verweij PE, Buil JB, de Hoog S, Liu J, Guo J, Liu W, Li R.   +7 more
europepmc   +1 more source

Epidemiology and Antifungal Susceptibility of Candida Bloodstream Isolates From a Tertiary Care Center in Central India. [PDF]

Cureus
Bhadade AA, Singh G, Karuna T, Panthi M, Beniwal A, Maurya AK, Upadhyay N, Reddy VR, Devgade A, Khadanga S.   +9 more
europepmc   +1 more source

Comparative Analysis of Isavuconazole DDIs With Other Azole Antifungal Drugs and PBPK Model-Informed Dosing Recommendations for Anticancer Drugs. [PDF]

CPT Pharmacometrics Syst Pharmacol
Goosen TC, Wu X, Lin J, Cheruvu N, Raber SR, de Figueiredo MLN, Varma MVS.   +6 more
europepmc   +1 more source

Mucormycosis in Paediatric Patients After Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. [PDF]

Mycoses
Lei Y, Zhang J, Han X, Liu X, Wang J.
europepmc   +1 more source

Real-world correlation between therapeutic drug monitoring and clinical outcomes of the antifungal drug posaconazole: a single-center retrospective cohort study. [PDF]

Front Pharmacol
Yi Q, Dong L, Wang P, Shi Y, Yang Y, Dong Z, Li S, Li Y, Huang X, Liu J, Shi H, Wang H.   +11 more
europepmc   +1 more source

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified-Release Posaconazole Prophylaxis. [PDF]

Transpl Infect Dis
Tio SY, Neoh CF, Ritchie D, Chee L, Kong DCM, Worth LJ, Yong MK, Slavin MA.   +7 more
europepmc   +1 more source